AZZ vs EXPO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AZZ has a weak Piotroski F-Score of 4/9, indicating marginal financial health, and lacks an Altman Z-Score for distress risk assessment. Despite strong profitability metrics like a 27.38% ROE and solid earnings growth, recent insider selling and declining EPS trends raise caution. The stock trades below the analyst target price but at a significant premium to the conservative Graham Number of $101.88, while forward P/E expansion suggests growth expectations are already priced in. Mixed signals from strong historical returns and solid margins against weakening recent earnings momentum result in a neutral stance.
EXPO shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 9/9). Key strengths include strong valuation and growth metrics. Price trades at a 60.8% premium to fair value estimate ($41.50), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
AZZ vs EXPO: Head-to-Head Comparison
This page compares AZZ Inc. (AZZ) and Exponent, Inc. (EXPO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.